Form 4 for SANA Sana Biotechnology, Inc.
Accepted 2022-06-15 00:00:00 ET · period of report 2022-06-13 · accession 0001562180-22-005121 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-06-15 | 2022-05-13 | SANA | MacDonald James J. | EVP, GC | A - Grant | $4.28 | +1,183 | 430.6K | +0.3% | +$5,063 |
| D | 2022-06-15 | 2022-06-13 | SANA | MacDonald James J. | EVP, GC | M - OptEx | $1.48 | +66.8K | 497.4K | +16% | +$98.9K |
| D | 2022-06-15 | 2022-06-13 | SANA | MacDonald James J. | EVP, GC | M - OptEx | $0.00 | -66.8K | 52.0K | -56% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-13 | A | A | 1,183 | $4.28 | 430,600 | D | — | — | (F2) In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on May 13, 2022. |
| 2 | Common | Common Stock | 2022-06-13 | M | A | 66,796 | $1.48 | 497,396 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2022-06-13 | M | D | 66,796 | $0.00 | 51,954 | D | $1.48 · — to 2030-01-26 | 66,796 Common Stock | (F3) 25% of the shares underlying the option vested and became exercisable on February 14, 2021, and the remainder of the shares underlying the option vest at a rate of 1/36th per month thereafter. |